Hycodan and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Hycodan (homatropine methylbromide; hydrocodone bitartrate), especially for people who are male, 60+ old, also take Levaquin, and have Arthritis.

The phase IV clinical study analyzes which people have Stroke when taking Hycodan. It is created by eHealthMe based on reports of 713 people who have side effects when taking Hycodan from the FDA, and is updated regularly.

What is Hycodan?

Hycodan has active ingredients of homatropine methylbromide; hydrocodone bitartrate. It is often used in cough. eHealthMe is studying from 769 Hycodan users. Check the latest studies of Hycodan.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,320 drugs and 3,028 conditions by eHealthMe. Check the latest studies of Stroke.

On Jun, 24, 2026

713 people reported to have side effects when taking Hycodan.
Among them, 26 people (3.65%) have Stroke.

Among these 26 people:

What is the gender of people who have Stroke when taking Hycodan? *

female: 10 %
male: 90 %

What is the age of people who have Stroke when taking Hycodan? *

What are other drugs people take besides Hycodan? *

What are other side effects people have besides Stroke? *

Dyspnea (difficult or laboured breathing): 19 people, 73.08%
Weakness: 18 people, 69.23%
Headache (pain in head): 18 people, 69.23%
Fatigue (feeling of tiredness): 18 people, 69.23%
Fainting (loss of consciousness and postural tone): 18 people, 69.23%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 17 people, 65.38%
Insomnia (sleeplessness): 17 people, 65.38%
High Blood Pressure: 17 people, 65.38%
Muscle Spasms (muscle contraction): 17 people, 65.38%
Pain: 17 people, 65.38%

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 17 people, 65.38%
Depression: 16 people, 61.54%
Nausea (feeling of having an urge to vomit): 16 people, 61.54%
Muscle Spasms (muscle contraction): 16 people, 61.54%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 16 people, 61.54%
Sleep Disorder: 16 people, 61.54%
Joint Pain: 2 people, 7.69%
Dyslipidaemia (abnormal amount of lipids): 1 person, 3.85%
Dementia (madness): 1 person, 3.85%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Hycodan and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hycodan:

Hycodan (769 reports)

Stroke treatments and more:

Stroke (334,635 reports)

How severe was Stroke and when was it recovered:

Stroke in Hycodan

Expand to all the drugs that have ingredients of homatropine methylbromide; hydrocodone bitartrate:

Stroke and drugs with ingredients of homatropine methylbromide; hydrocodone bitartrate (508 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hycodan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,320 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,028 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on homatropine methylbromide; hydrocodone bitartrate (the active ingredients of Hycodan) and Hycodan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.